Yabao Pharmaceutical announced that the company plans to repurchase shares using 100 million yuan to 200 million yuan of its own capital to cancel and reduce registered capital. The repurchase period is from August 18, 2026 to August 17, 2027. The upper limit of the repurchase price was adjusted to 6.75 yuan/share due to semi-annual equity distribution, effective from September 1, 2026. On September 11, 2026, the company repurchased 200,000 shares for the first time through centralized bidding, accounting for 0.03% of the total share capital. The repurchase price range was 6.58 yuan/share - 6.59 yuan/share, and the total payment amount was 1,317 million yuan.

Yabao Pharmaceutical announced that the company plans to repurchase shares using 100 million yuan to 200 million yuan of its own capital to cancel and reduce registered capital. The repurchase period is from August 18, 2026 to August 17, 2027. The upper limit of the repurchase price was adjusted to 6.75 yuan/share due to semi-annual equity distribution, effective from September 1, 2026. On September 11, 2026, the company repurchased 200,000 shares for the first time through centralized bidding, accounting for 0.03% of the total share capital. The repurchase price range was 6.58 yuan/share - 6.59 yuan/share, and the total payment amount was 1,317 million yuan.